NEXT FUNDS TOPIX-17 Pharmaceutical ETF (TYO:1621)
31,110
-640 (-2.02%)
At close: Feb 6, 2026
TYO:1621 Holdings Information
TYO:1621 is an equity ETF with a total of 33 individual holdings. The top holdings are Takeda Pharmaceutical Company stock at 25.94%, Chugai Pharmaceutical at 14.46%, Daiichi Sankyo Company at 14.18%, Otsuka Holdings at 11.13%, and Astellas Pharma at 10.47%.
Total Holdings
33
Top 10 Percentage
91.73%
Asset Class
Equity
ETF Category
Health Care
Assets
5.78B
PE Ratio
24.41
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | TYO: 4502 | Takeda Pharmaceutical Company Limited | 25.94% |
| 2 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 14.46% |
| 3 | TYO: 4568 | Daiichi Sankyo Company, Limited | 14.18% |
| 4 | TYO: 4578 | Otsuka Holdings Co., Ltd. | 11.13% |
| 5 | TYO: 4503 | Astellas Pharma Inc. | 10.47% |
| 6 | TYO: 4507 | Shionogi & Co., Ltd. | 6.54% |
| 7 | TYO: 4523 | Eisai Co., Ltd. | 3.08% |
| 8 | TYO: 4528 | Ono Pharmaceutical Co., Ltd. | 2.89% |
| 9 | TYO: 4536 | Santen Pharmaceutical Co., Ltd. | 1.57% |
| 10 | TYO: 4151 | Kyowa Kirin Co., Ltd. | 1.46% |
| 11 | TYO: 4527 | Rohto Pharmaceutical Co.,Ltd. | 1.42% |
| 12 | TYO: 4506 | Sumitomo Pharma Co., Ltd. | 1.08% |
| 13 | TYO: 4530 | Hisamitsu Pharmaceutical Co., Inc. | 0.76% |
| 14 | TYO: 4540 | Tsumura & Co. | 0.75% |
| 15 | TYO: 4516 | Nippon Shinyaku Co., Ltd. | 0.71% |
| 16 | TYO: 4887 | Sawai Group Holdings Co., Ltd. | 0.65% |
| 17 | TYO: 4587 | PeptiDream Inc. | 0.40% |
| 18 | TYO: 4547 | Kissei Pharmaceutical Co., Ltd. | 0.39% |
| 19 | TYO: 4521 | Kaken Pharmaceutical Co., Ltd. | 0.32% |
| 20 | TYO: 4553 | Towa Pharmaceutical Co., Ltd. | 0.26% |
| 21 | TYO: 4534 | Mochida Pharmaceutical Co., Ltd. | 0.24% |
| 22 | TYO: 4565 | Nxera Pharma Co., Ltd. | 0.20% |
| 23 | TYO: 4549 | Eiken Chemical Co., Ltd. | 0.19% |
| 24 | TYO: 4569 | KYORIN Pharmaceutical Co., Ltd. | 0.18% |
| 25 | TYO: 4559 | Zeria Pharmaceutical Co., Ltd. | 0.15% |
As of Feb 4, 2026